Best UK mortgage deals of the week

Find out the latest mortgage rates and deals from HSBC, NatWest, Santander, Barclays and more

Royalty Pharma plc (RPRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

27.88

-0.12

(-0.43%)

At close: 04:00PM EDT

28.28

+0.40

(+1.43%)

After hours:

06:33PM EDT

Currency in USD

Earnings estimate	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
No. of analysts	6	6	7	7
Avg. Estimate	0.97	0.96	3.94	4.39
Low estimate	0.92	0.88	3.68	4.1
High estimate	1.06	1.04	4.2	4.67
Year ago EPS	0.84	0.79	4.5	3.94

Revenue estimate	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
No. of analysts	4	4	7	7
Avg. Estimate	616.15M	661.83M	2.61B	2.87B
Low estimate	577.19M	556.78M	2.34B	2.54B
High estimate	681.01M	724.55M	2.76B	3.12B
Year ago sales	N/A	536.31M	2.35B	2.61B
Sales growth (year/est)	N/A	23.40%	10.70%	10.00%

Earnings history	29/06/2023	29/09/2023	30/12/2023	30/03/2024
Est. EPS	0.81	0.76	1.01	0.98
Actual EPS	0.84	0.79	1.15	0.98
Difference	0.03	0.03	0.14	0
Surprise %	3.70%	3.90%	13.90%	0.00%

EPS trend	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
Current estimate	0.97	0.96	3.94	4.39
7 days ago	0.96	0.98	3.78	4.17
30 days ago	0.96	0.98	3.8	4.14
60 days ago	0.92	0.95	3.77	4.12
90 days ago	0.85	0.86	3.64	4.09

EPS revisions	Current qtr. (Jun 2024)	Next qtr. (Sep 2024)	Current year (2024)	Next year (2025)
Up last 7 days	1	N/A	1	1
Up last 30 days	2	1	3	4
Down last 7 days	N/A	N/A	N/A	N/A
Down last 30 days	N/A	1	3	2

Growth estimates	RPRX	Industry	Sector(s)	S&P 500
Current qtr.	15.50%	N/A	N/A	N/A
Next qtr.	21.50%	N/A	N/A	N/A
Current year	-12.40%	N/A	N/A	N/A
Next year	11.40%	N/A	N/A	N/A
Next 5 years (per annum)	3.20%	N/A	N/A	N/A
Past 5 years (per annum)	41.66%	N/A	N/A	N/A